GRCE

Grace Therapeutics, Inc. Common Stock

20 hedge funds and large institutions have $11.3M invested in Grace Therapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 1 closing their positions.

Holders
20
Holders Change
+3
Holders Change %
+17.65%
% of All Funds
0.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
7
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
NCM
1
Nantahala Capital Management
Connecticut
$3.5M 1,178,203
ACM
2
AIGH Capital Management
Maryland
$3.35M 1,128,497 -193,882 -15%
Bank of America
3
Bank of America
North Carolina
$1.47M 494,698
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.22M 409,100 +153,700 +60%
SCM
5
Stonepine Capital Management
Oregon
$869K 292,500 -2,050 -0.7%
ACM
6
ADAR1 Capital Management
Texas
$525K 176,627 -166,885 -49%
PWM
7
Palumbo Wealth Management
New York
$144K 48,541 +2,534 +6%
Citadel Advisors
8
Citadel Advisors
Florida
$102K 34,382 -4,021 -10%
Renaissance Technologies
9
Renaissance Technologies
New York
$82K 27,625 -14,556 -35%
MFA
10
Millington Financial Advisors
Illinois
$67K 20,000 +20,000 New
National Bank of Canada
11
National Bank of Canada
Quebec, Canada
$8.07K 2,716 -2 -0.1%
Morgan Stanley
12
Morgan Stanley
New York
$5.49K 1,848
TRCT
13
Tower Research Capital (TRC)
New York
$4.01K 1,351 -2,078 -61%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$2K 543
AWM
15
Activest Wealth Management
Florida
$309 104
SS
16
SBI Securities
Japan
$300 101
SPIA
17
Steward Partners Investment Advisory
New York
$122 41 +41 New
Jones Financial Companies
18
Jones Financial Companies
Missouri
$86 29 +29 New
FDCDDQ
19
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3 1
Citigroup
20
Citigroup
New York
$3 1 +1 New
JPMorgan Chase & Co
21
JPMorgan Chase & Co
New York
-15 Closed